Clinical Trial Update: D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating D-Cycloserine augmentation of exposure-based CBT for smoking cessation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Boston University Charles River Campus | Conditions: Smokers | Phase 2 | Status: WITHDRAWN